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The major histocompatibility (H) 1  effects in mouse are primarily associated with 
genetic disparity in a single region known as H-2, loci of" which control expression 
of H  determinants recognized  as  foreign  by  a  host  and  that  initiate  events 
resulting in rejection. Congenic strains of mice, presumed genetically identical 
except for H-2,  have been useful in understanding the role of' this region in the 
stimulation of allograft responses. Recombinant strains differing for only parts of 
the H-2 region have helped elucidate the complexity of genetic control by H-2. 
Two genetically and functionally separate H antigens have been distinguished 
which are  controlled by loci of H-2.  One type of antigen, upon immunization, 
primarily elicits the formation of cytotoxic and/or agglutinating antibodies which 
react  with  cell  surface  antigens  on  all  lymphocytes and  essentially all  other 
tissues.  The  antibodies  are  used  to  type  (serologically  define)  these  deter- 
minants. Such antigens are designated  SD antigens and the H-2 loci, H-2K and 
H-2D,  controlling them as Hsd (histocompatibility SD) loci. The second type of 
H  determinant leads to lymphocyte activation as measured in the mixed leuko- 
cyte culture (MLC) test (1, 2). Such determinants are called LD and the H-2 loci 
controlling their expression Hld (histocompatibility LD)  loci. The designations 
"SD" and "LD" are used to refer to these H  differences as  a  descriptive ter- 
minology for distinguishing them. 
The differential H effects of LD and SD determinants have been examined in 
two  in  vitro  test  systems  used  as  models  for  allogeneic  interactions.  Initial 
recognition in an allogeneic response leads to enlargement and proliferation of 
responding  cells.  This  response  is,  at  least  in  part,  assessed  in  MLC  tests. 
Lymphocytes sensitized in MLC to alloantigens acquire the ability to specifically 
lyse  target  cells  bearing  these  same  antigens,  a  response  measured  in  cell- 
*This  is  paper  No.  1,777 from  the  Laboratory  of  Genetics  and  paper  no.  1,777  from  the 
Immunobiology Research Center,  University of Wisconsin,  Madison,  Wisconsin. 
Supported by  NIH grants  GM-15422, CA-14520, AI-08439, and AI-11576, and  National Foun- 
dation-March of Dimes grant CRBS 246. 
§ NIH Trainee supported by NIH grant GM-00398. 
1Abbreviations  used  in  this  paper:  CML,  cell-mediated  lympholysis;  H,  histocompatibility, 
[SH]TdR, [3H ]thymidine; LD, lymphocyte defined; LPS, lipopolysaccharide;  MLC, mixed leukocyte 
culture; MR, maximum release; PHA, phytohemagglutinin; SD, serologically defined;  SR, spontane- 
ous release. 
1534  THE JOURNAL EXPERIMENTAL MEDICINE • VOLUME 140, 1974 DOLORES  J.  SCHENDEL  AND  FRITZ  H.  BACH  1535 
mediated  lympholysis  (CML)  assays  (3). Clear  distinctions  can be drawn  between 
LD  and  SD  determinants  in stimulation  of these  allogeneic  responses;  this paper 
presents  a  detailed  analysis  of the roles of LD and  SD  in the generation  of CML. 
Materials  and Methods 
Experimental  Protocol.  Spleen cells from  mouse strain A  are  cultured  in one-way MLC  with 
mitomycin C-inactivated spleen cells from strain B. After 4 or 5 days of incubation MLC proliferation 
is determined by measuring the amount of [3H]thymidine ([aH]TdR) incorporated by the A dividing 
cells. The effector capacity of A cells to lyse B target cells is examined in CML by incubating the A 
cells (sensitized for 4 days in MLC) with sodium ~aC-labeled phytohemagglutinin (PHA) blasts from 
strain B. During the 3-h incubation B cells which are damaged by A effector cells release their 5~Cr 
into the culture medium. 
A  positive proliferative response is defined as one in which the counts per minute of  [3H]TdR 
incorporated by ABm cultures is significantly greater than counts per minute incorporated by AA~ 
control cultures. A positive CML response is defined as one in which effector cells sensitized in an 
ABm MLC cause specific release of 51Cr from B target cells which is greater than that released from A 
target cells. 
Mice.  Mice used in the studies were bred in our colony at the University of Wisconsin; breeding 
pairs were kindly supplied by Doctors. J. Klein (University of Texas, Dallas, Texas), G. Snell (Jack- 
son Laboratories, Bar Harbor, Maine), and J. Stimpfling, McGlaughlin Research Institute, Columbus 
Hospital,  Great Falls,  Mont.  Male  and female mice between  1 and 6  mo of age were used.  With 
one exception, AQR, all mice were congenic on a C57BL/10 Sn (B10) background, presumably differ- 
ing for only H-2.  Origin of the various recombinant strains has been summarized elsewhere (1).  Al- 
though the AQR line is not congenic with B10,  it carries a  considerable portion of the B10 genome 
having undergone four backcrosses to a  B10 parent before being established by intercrossing. Pre- 
vious studies would indicate that in vitro responses of this strain are primarily governed by H-2 (1). 
The H-2 complex may be subdivided into four regions, K, I, S, and D, arranged in that order from 
left to right on the ninth linkage group. The two outer regions, K and D, contain the Hsd loci, alleles 
of which determine SD antigens. The I region contains immune response loci; these loci determine the 
ability of an animal to mount an immune response against certain antigens. Between I and D  is a 
fourth region, S,  marked by the Ss locus which controls quantitative levels of a  serum protein. One 
Hid locus has been formally mapped between S and D, and a second locus is presumably located in 
the I region (2, 4). 
In individual strains of mice the four regions may be designated by four letters according to their 
origins. For instance, the genotype of strain B10.A, which carries the H-2  a chromosome, is kkdd,  it 
has the K and I regions derived from an H-2  k chromosome, and the S and D regions derived from an 
H-2  a chromosome. Individual strain genotypes are listed in parentheses in tables. 
Functional tests are used to define LD and SD phenotypes of particular mouse strains. Two mice 
are  defined  as  LD  different  and  SD  identical  if the  genetic  disparity  between  them  results  in 
significant MLC  proliferation, yet serological studies reveal no detectable differences for SD-type 
antigens. (They may differ by Ia-type antigens which are present on only some lymphoid cells  [5].) 
Alternatively two mice are referred to as SD different if their disparity includes loci that determine 
different SD specificities and they are not known to be different for the two common Hld loci defined 
above. It is not possible to define critically the complete LD  relationship of such  mice since any 
detectable MLC proliferation could be induced either by SD antigens themselves or by separate LD 
antigens determined by genes located in the K or D region (marked by the Hsd loci). This point must 
be kept in mind when one compares animals that have SD differences, these animals differ for entire 
genetic regions; only part of the genetic material included in such a region may code for SD antigens 
and it is possible that loci coding for LD antigens may also be present. Thus even though we describe 
two animals as being "SD different" the reader should be aware of the greater genetic complexity 
involved. 
MLC Test.  The MLC system used was a combined modification of the methods of Widmer and 
Bach (6) and Phillips et al. (7).  40  ×  10 '  responding cells were incubated with 60  ×  10 e mitomycin 1536  GENETIC  CONTROL OF CELL-MEDIATED  LYMPHOLYSIS IN  MOUSE 
C-inactivated  stimulating  cells  in  upright  culture  flasks  (Falcon  3012,  Falcon  Plastics,  Div.  of 
BioQuest, Oxnard, Calif.). When stimulating cells of two different types were used (i.e., in three-cell 
cultures) 30  x  10" cells of each type were combined to give a  total of 60  ×  106 stimulating cells. 
Cultures using only one type of stimulating cell were kept at the same cell concentration by adding 
mitomycin C-inactivated cells syngeneic to the responding cell. 
The culture  medium used was RPMI  1640 (Grand Island Biological Co.,  Grand Island,  N.  Y.), 
supplemented with penicillin, streptomycin, and 5% heat-inactivated (56 ° C, 30 min) pooled human 
plasma. After 88-90 h (day 4) or 104-106  h (day 5) of culture, 200 #l aliquots were removed to assess 
proliferation by  [SH]TdR incorporation. These samples were labeled with 2 #Ci  [SH]TdR (sp. act 1.9 
Ci/mmol) for 4-6 h. The remaining cell suspension was used in the CML assay. 
Heat treatment of stimulating cells was carried out at 45 ° C for 60 min. Cells were washed once in 
culture medium after the heat treatment. 
CML Assay.  Preparation of PHA target cells and the CML assay were carried out according to 
the method previously described (8). Lipopolysaccharide (LPS) targets were prepared by incubating 
spleen cells (5 × 10 e cells/ml) in 3-ml aliquots in RPMI 1640 with 5% heat-inactivated human plasma. 
48 h  before use they were stimulated with 50 #g/ml of LPS (Escherichia  coil) (Difco Laboratories, 
Detroit, Mich.). MLC blasts were obtained from cultures set up according to the micromethod of 
Widmer and Bach (6); they were used after 3 days of culture. Normal fresh target cells were prepared 
from lymph node cells suspensions on the day of the CML assay. 
The maximum release (MR) value of each target cell preparation was measured by determining 
the amount of 51Cr released into the supernatant fluid by 1 ×  104 target cells after freeze-thawing 
three times. Spontaneous release (SR) of 51Cr from the same number of target cells, incubated for 3 h 
with 1  ×  10 e freshly prepared lymph node cells, was also measured. The percent specific chromium 
release was calculated according to the formula: (experimental release -  SR)/(MR -  SR)  x  100. All 
assays were done in triplicate. 
Results and Discussion 
Initial studies concerning in vitro MLC and CML responses after stimulation by 
LD  and  SD  determinants  revealed  several  differences.  It  was  observed  that 
stimulation  by  LD  differences alone  produced  strong  proliferative  responses 
whereas stimulation by  SD  regions did  not lead to activation, or did  so only 
weakly (1, 2). LD differences, with one exception (9), did not generate detectable 
cytotoxic activity and did not serve as good targets for lysis; while SD differences 
were  important  in  generation  of cytotoxic  potential  and  were  recognized by 
effector cells  as  targets  (8,  10,  11)  or  served  as  markers  for the  actual target 
detected in CML (9, 12). Cases were noted where stimulation by either LD or SD 
determinants alone failed to produce detectable cytotoxic activity, but sensitiza- 
tion to both LD and SD at the same time led to positive CML reactions (8, 12). 
The Role of LD Determinants as Targets for CML.  As previously reported we 
have  examined CML responses  of strain  pairs  that  are  LD  different and  SD 
identical (8). MLC proliferation is observed but cytotoxic responses are negative. 
Several  factors  must be  considered  when  interpreting the  failure to obtain 
CML in combinations differing for LD. A number of technical difficulties may 
limit  detection  of cytotoxic activity.  Objections  have  been  raised  concerning 
suitability of PHA blasts as targets for lysis directed toward LD determinants. 
We have utilized other types of target cells in CML to determine whether they are 
more  sensitive  for  finding  LD  destruction.  Table  I  compares  CML  on  four 
different target populations. PHA blasts were used as monitors for the standard 
CML  technique.  Spleen  cells  were  stimulated with  LPS  to  produce  a  blast DOLORES  J.  SCHENDEL  AND  FRITZ  H.  BACH 
TABLE  I 
Comparison of Various Types of Target Cells 
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Effector combination  Target cell  PHA-M  LPS  MLC  Normal 
AQR  ÷  B10.T(6R}m  AQR  -0.78 ±  4.1  -9.4 =~ 3.1  -  1.1 ±  1.8  7.4 =e 6.1 
(qkdd}  (qqqd)  B10.T(6R)  3.4 =e 3.4  8.6 ±  4.2  7.1 ±  3.6  -  1.4 =e 7.8 
B10.A  -3.1 ±  3.7  -3.4 ±  4.6  -0.07 ±  3.1  -6.9 :e 3.6 
AQR  +  B10.A~  AQR  -10.4 =~ 3.6  -16.8 ±  4.4  -1.9 ±  1.4  -9.8 =e 4.9 
(qkdd)  (kkdd)  B10.T(6R)  -1.6 ±  4.5  -10.4 ±  4.7  5.1 ±  2.6  7.7 :e 7.4 
B10.A  69.3 ±  8.1  54.8 ±  4.2  30.5 ±  7.1  11.7 ±  3.7 
The data are expressed as % CML (mean  ±  SD) obtained after 1  x  10  e effector cells were incubated with 1  x  10  ~ 
target cells for 3 h. 
population primarily of B-cell type; we wished to examine such a target because 
of reports that LD determinants may be preferentially expressed on B cells (5). 
MLC blasts were prepared in an attempt to clonally expand the population of 
cells  recognizing one  LD  determinant thereby possibly expanding those  cells 
which express  LD determinants on their surface as  well  (13);  these cells also 
eliminated potential effects due to alternations in surface antigens caused by 
nonspecific stimulation. Finally untreated lymph node cells were also examined; 
we know that LD is expressed on these cells in such a manner as to cause MLC 
(D. J. Schendel, unpublished observations). 
Essentially identical patterns of response are noted on the four targets. In AQR 
plus B10.T(6R)m, in which there is sensitization to only LD differences, there is 
no significant, specific lysis of B10.T(6R)  targets. Thus the pattern of cytotoxic 
reactivity to LD determinants is not altered by substituting other types of target 
cells. AQR plus B10.Am produces effector cells that are cytolytic to B10.A targets 
regardless of their manner of preparation.  PHA and LPS  blasts show similar 
levels of susceptibility to lysis while MLC blasts and normal untreated targets 
show lower levels of destruction. PHA blast cells are more susceptible to lysis 
than normal small lymphocytes; fresh cells, of course, are small lymphocytes and 
MLC blast  preparations contain considerable numbers of nonblast cells.  This 
difference most likely accounts for the various levels of lysis observed. 
Relatively high levels of spontaneous release of ~lCr label from target cells and 
the ratio of effectors to targets required to measure CML could contribute to an 
inability  to  detect  relatively  weak  cytotoxic  responses  with  LD  different 
combinations. On occasion in single experiments we have observed low levels of 
cytotoxicity (3.1-10.4%)  when AQR plus B10.T(6R)m effector cells are incubated 
with B10.T(6R) targets. This may indicate that LD can serve as a poor target in 
CML, however this activity has not been consistently reproduced. 
In support  of possible  low level CML on LD one significant trend has been 
noted  in  repeated  experiments  testing  the  effector  capacity  of  AQR  plus 
B10.T(6R)m  on various target cells. In 12 of 15 separate experiments the mean 
percent CML measured on B10.T(6R) targets was greater than that observed on 
AQR targets, syngeneic to the responding cell, and in 13 of 15 experiments the 
lysis  of B10.T(6R)  targets  was  greater than  that  of unrelated  B10.A  targets. 
These values are significantly different from random chance (chi-square) with P 1538  GENETIC  CONTROL  OF  CELL-MEDIATED  LYMPHOLYS|S  IN  MOUSE 
values of <0.02 and <0.005,  respectively, and may indicate detection of a  very 
weak response directed at either LD determinants or other weak non-SD targets. 
Detection  of weak  but  significant  CML  responses  with  the  B10.A(4R)  plus 
B10.A(2R)  or  B10.A(1R)  combinations  (LD  different, SD  identical)  has  been 
observed. 2 
It must be stressed that the level of lysis of Bt0.T(6R) targets is extremely low 
in comparison to that observed in other allogeneic combinations where lysis is 
directed  against  SD  determinants.  A  compilation  of data  obtained  from  20 
separate experiments is presented in Table II. In AQR plus B10.T(6R)~ the mean 
percent  CML  is  4.8%,  and  in  AQR  plus  B10.T(6R)m  plus  B10.A~  where 
sensitization to both LD and SD  is possible an average of only 1.1% lysis is ob- 
tained on the LD target--in sharp contrast to an average of 60.2% noted on the 
SD-bearing target cell. 
TABLE  II 
Summary of 20 Experiments Testing Cytotoxic Activity After Stimulation by LD 
Alone or LD + SD 
Effector combination 
CML (mean ±  SD) 
AQR  B10.T(6R)  B10.A 
AQR +  B10.T(6R)m 
AQR +  B10.T(6R)m +  B10.Am 
%  %  % 
-12.5 ±  13.8  -4.8 ±  10.0  -9.5 ±  10.5 
-8.0 ±  13.9  1.1 ±  14.0  60.2 ±  33.5 
These results indicate a  sharp  disparity between LD-different combinations 
and other allogeneic combinations as tested in CML. With currently available 
techniques for generating effector cells and possible target cells for measuring 
lysis, any cytotoxic activity in LD combinations is at least an order of magnitude 
less than that observed when SD-region differences are also used for sensitization 
and as targets. The results however do not rule out the possibility that LD can 
stimulate strong cytotoxic responses both in vivo and in vitro, and given more 
sensitive techniques such responses will eventually be measured. 
Finally,  note  should  be  made  of one  discrepancy found in  this  pattern  of 
cytotoxic responses of LD-different combinations; one LD-different, SD-identi- 
cal strain  combination does respond differently. C57BL/6-H(zl)  shows strong, 
reciprocal cytotoxic responses (9).  This dichotomy may be explained by one of 
several possibilities which have been discussed in the past (9,  12). 
Interaction of LD and SD in the Generation of CML.  Collaboration between 
LD and SD in generating CML is most easily studied in three-cell experiments 
where the determinants are presented on separate stimulating cells. An example 
of  such  a  three-cell  experiment  is  presented  in  Table  III.  B10.T(6R)  is  the 
responding population and LD sensitization is provided by AQRm cells. B10.Gm 
2 Peck,  A., and F.  Bach.  1974.  Mouse cell-mediated  lympholysis assay in serum-free and mouse 
serum-supplemented media: culture conditions and genetic factors. Scand. J. Immunol. In press. DOLORES  J.  SCHENDEL  AND  FRITZ  H.  BACH 
TABLE  III 
A  Three-Cell Experiment 
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Effector combination  Genetic  MLC 
stimulation  (mean ±  SD) 
CML (mean ± SD) 
AQR  B10.T(6R)  B10.G 
cpm  %  %  % 
B10.T(6R)  +  AQR~  LD  16,817 ±  763  -3.1 ±  2.2  -3.9 ± 0.91 
(qqqd)  (qkdd) 
B10.T(6R)  +  B10.Gm  SD  5,852 ± 480  -1.4 ± 2.0  4.3 ±  1.5 
(qqqq: 
B10.T(6R)  +  AQR~  LD + SD  24,334  ± 508  0.48 ± 2.6  -1.9 ±  1.9  21.4 ±  2.2 
+  B10.G~ 
B10.T(6R)  +  B10.T(6R)m  --  2,473  ±  152  -2.2 ±  1.4 
cells present SD determinants; in this case SD disparity is associated with H-2D 
locus differences. Sensitization of B10.T(6R) to only LD (AQRm) produces strong 
proliferation, but generates no CML. SD  sensitization by B10.Gm  alone shows 
minimal proliferation and cytotoxicity. In three-cell cultures where both LD and 
SD  determinants  are  used  for simultaneous sensitization,  one  observes  both 
MLC proliferation and CML. Following the consistently seen pattern, cytotoxic 
activity  is  only  detected  when  effector  cells  are  incubated  with  B10.G  (SD 
different) targets. 
This experiment provides an example of a situation in which sensitization by 
either LD or SD antigens alone does not stimulate strong cytotoxic potential, but 
together they collaborate to generate specific CML which is directed towards SD 
targets. This three-cell experiment,  together with a  similar experiment previ- 
ously  described  (12),  demonstrate  that  LD  differences  collaborate  with  SD 
differences due to either H-2K or H-2D genetic disparity to produce cytotoxic 
effector cells. 
Initial studies failed to show CML with many SD  combinations differing at 
only K or D. Using altered culture techniques it has now been possible to obtain 
CML  effectors  in  most  SD  combinations.  Even  in  these  situations  where 
stimulation by SD alone can lead to CML, a collaborative effect with stimulation 
by both LD and SD during the MLC sensitization phase produces an enhanced 
CML response compared to that detected when only SD differences are used for 
stimulation. Fig.  1 illustrates the cytotoxic potential of cultures stimulated by 
SD  region  differences  alone  (AQR  plus  B10.Am)  and  those  stimulated  by 
both LD and  SD  differences  [AQR  plus  B10.T(6R)m  plus B10.Am].  Data from 
AQR  plus  B10.T(6R)m  cultures  (LD  alone)  is  not  presented as  no  significant 
CML response is detected. A linear relationship between the log of the number of 
effector cells and percent CML is observed in both cases. Because the slopes of 
the two lines are parallel a comparison of activities of the two cytotoxic popula- 
tions can be made. 
Table IV summarizes comparisons between amounts of CML when SD alone 
and LD plus SD stimuli are present in MLC. At any ratio, effector cells generated 
by stimulation with LD plus SD differences cause approximately 20% more lysis 
of SD  targets. The number of effectors required to cause 50%  lysis of a  given 
number  of targets  is  4.2-fold  less  in  LD-enhanced  cultures  compared  to  the 1540  GENETIC CONTROL OF  CELL-MEDIATED LYMPHOLYSIS  IN  MOUSE 
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Fro. 1.  The cytotoxic activity of effector cells stimulated by an SD region alone (O) and; 
stimulated by LD  plus  SD  (@). Different numbers  of effector cells are combined with  a 
constant number of target cells (1  ×  10'). 
TABLE  IV 
Cytotoxic Activity of Effector Populations Sensitized to SD Determinants Alone and to 
(LD + SD) Determinants 
Genetic 
Effector combination  stimulation  Target  CML* 
No. ef-  No. el-  No. 
fectors =  fectors/  LU$/ 
50% lysis  culture  culture 
% 
AQR +  B10.Am  SD  B10.A  44  4.2 x 10 s  4.5 × 108  10.7 
(qkdd)  (kkdd) 
AQR +  B10.Am  LD + SD  B10.A  66  1.0 x 10 ~  8.1 x 106  81.0 
+  B10.T(6R)m 
(qqqd) 
* The % CML indicated is that obtained when 25 x 10' effector cells are incubated with 1 × 10' B10.A 
target cells. 
Lytic units (LU) are calculated according to the formula (no. effectors/culture)/(no, effectors -  50% 
lysis). 
cultures  sensitized  to  SD  alone.  Not  only  is  this  specific  activity  of  effector 
populations different in the two cultures, but also there is a  twofold difference in 
the  number  of  effector  cells  recovered  per  culture.  Using  the  preceding  two 
values  one  can  calculate  the  number  of  lytic  units  obtained  per  culture  by 
dividing  the  number  of effector  cells  recovered  per  culture  by  the  number  of 
effector  cells  causing  50%  lysis.  When  these  values  are  determined  for  both 
effector  populations  in  eight-fold increase  is  observed  in  effectors  activated  by 
LD  plus SD compared  to SD  stimulation  alone. 
In  evaluating  the  role  of LD  enhancement  of cytotoxicity one  possibility to 
consider was that  equally strong proliferation and cytotoxicity could occur with 
stimulation  by  SD  alone  and  stimulation  by  LD  plus  SD  but  peak  responses 
might occur at different times. This possibility was tested in kinetic studies with 
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FIG. 2a and b.  The kinetics  of MLC and CML of effector  cells stimulated  by an SD region 
alone (©) and stimulated by LD plus SD (Q). 
liferation (Fig. 2 a) is seen on day 4 in both cultures. Cytotoxic responses of both 
effector populations peak on day 5, 24 h  after the MLC peak activity (Fig. 2 b). 
By day 6, CML in cultures sensitized to SD alone is falling off as it is in cultures 
stimulated  by  LD  plus  SD.  At  no  time  do  responses  of  the  SD-different 
combination reach the peak levels of response seen with stimulation by both LD 
plus SD. 
Is collaboration by LD an essential event or only a  helper effect? Examples 
have been cited where neither LD nor SD alone stimulate CML but combined 
sensitization does; such results would indicate an obligate need for LD. However, 
stimulation by  SD-region  differences alone  can  also  produce  CML responses 
under some conditions (Fig. 1). It must be emphasized again that when we speak 
of two strains having SD  differences we are speaking of strains that differ for 
entire SD  regions, and certainly only part of the genetic material contained in 
such a region is coding for SD antigens. Clearly, SD-region differences alone are 
not  totally  incapable  of  activating  MLC  proliferation  (1).  The  SD  regions 
themselves may contain quantitatively weaker Hld loci that can interact with 
SD  antigens of the same region to produce CML. We have obtained evidence 
from one series of experiments which provide data consistent with the hypothesis 
that there are in fact LD-like determinants in the K region of B10.A which are 
recognized by AQR and collaborate with SD antigens to produce CML. 
In human CML studies Eijsvoogel et al. demonstrated that heat treatment of 
an  allogeneic-stimulating  cell  destroyed  its  ability  to  cause  strong  MLC 
proliferation but left its ability to sensitize for CML, provided an LD difference 
was supplied by another nonheat-treated cell (14).  In addition, heat treatment 
has been  shown to  have no effect upon the  ability of cells to absorb  anti-SD 
antibody. These results indicate that heat treatment affects LD but leaves SD 
unaffected. We have studied effects of heat treatment in the three-cell system. 
Particularly we wished to focus upon the question of whether AQR and B10.A 
(SD-region different) have weak LD differences located in the SD region which 
collaborate to produce CML effectors. 
The rationale of the experiment was to use heat treatment to damage any LD 
differences on the B10.A-stimulating cell while leaving SD antigens intact. One 1542  GENETIC  CONTROL OF CELL-MEDIATED  LYMPHOLYSIS IN MOUSE 
could then determine whether SD  antigens  themselves produce CML effectors. 
Table V shows results of such a heat treatment experiment. The first set of data 
shows control values for the normal experimental system using mitomycin C to 
inactivate stimulating  cells.  The  SD  combination under these conditions gives 
positive  proliferation and  eytotoxicity, and  CML is  enhanced  in  the three-cell 
combination where both LD and  SD are used as stimuli.  When heat treatment 
(A)  is substituted for mitomycin C  inactivation essentially all  CML activity is 
lost.  The  last  two  lines  show  responses  when  both  treatments  are  combined. 
When  the  LD-stimulating  cell  is  heat  treated  and  the  SD-stimulating  cell  is 
inactivated with mitoymcin C, CML is not significantly different from that seen 
with SD stimulation  alone in the normal system (25% vs.  22%).  More interest- 
ingly though when the SD-stimulating cell is heat treated and the LD-stimulat- 
ing cell is mitomycin C inactivated, CML is as high as that seen in normal three- 
TABLE  V 
The Effect of Heat Treatment of Stimulating Cells  on the 
Generation of Cytotoxic Responses 
MLC activation*  % CML$ 
Effector combination  (mean ± SD)  (mean ± SD) 
AQR + B10.Am 
AQR + B10.Am + B10.T(6R)m 
cpm 
4,113 ±  190  21.8 ±  2.2 
8,292 =~ 309  40.4 ±  2.8 
AQR +  B10.A~§  4,332 ±  89  3.1  ±  1.9 
AQR +  B10.A~ +  B10.T(6R)~  5,771  ±  301  -3.2 ±  2.6 
AQR + B10.A~, + B10.T(6R)A 
AQR + B10.AA  + B10.T(6R)o 
8,771 i  287  25.3 ±  3.5 
17,375  ±  426  42.7 ±  2.9 
*The AQR  +  AQRm cultures gave 2,926  ±  254  cpm and AQR +  AQR± 
gave 2,316  ±  107 cpm. 
$ The % CML of the B10.A target cell is presented. 
§ A, 45°C for 60 min. 
cell cultures (43% vs. 40%). Heat treatment abolishes cytotoxicity of populations 
stimulated  by SD  alone or  by both  LD and  SD;  but  CML  can  be restored by 
adding back a normal LD stimulus on a  mitomycin C-treated cell. This indicates 
that  in  AQR  plus  B10.A~  the  SD-region  difference is  still  expressed  in  such  a 
manner that it can sensitize for target recognition, but it is critically affected in 
its  ability  to  produce  cytotoxic  effector  cells  without  an  added  normal  LD 
stimulus.  Thus  heat  treatment  may  actually  be  damaging  an  LD  difference 
which  is  controlled by a  locus  closely linked  to the H-2K  locus  of B10.A  and 
located within the SD (K) region. If this interpretation is correct it would suggest 
that  collaboration  between  LD  and  SD  is  essential  in  generation  of  CML. 
Alternatively one could argue that heat treatment affects only one molecule (i.e., 
the SD antigen) but molecular requirements for proliferation and cytotoxicity are 
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Heat treatment  does not  in  all cases totally eliminate proliferation.  However 
the  lower  percentage  of cells  recovered from cultures  having only heat-treated 
stimulating cells indicates that proliferation is being affected, and the degree of 
this effect may not be totally apparent when proliferation is measured beyond the 
time of peak MLC activity. In this experiment both MLC proliferation and CML 
were assessed on day 5. 
General Discussion 
H-2  contains  genetically  distinct  loci  which  control  at  least  two  types  of  H 
antigens,  the  LD and  SD  components.  In  addition  to being able to genetically 
dissect these determinants certain functional distinctions between them can also 
be made. 
Genetic  separability of LD  and  SD  is  based  on  classical  genetic  recombination;  the 
functional dichotomy is less clearly established but seems well taken on several grounds. 
Primarily H-2 LD-type differences lead to strong proliferation of T lymphocytes in MLC 
while "serving" as poor targets in CML; H-2 SD-type differences are relatively weak in 
causing  proliferation  but  serve  as  excellent  targets.  Since  we  cannot  differentiate 
experimentally between the ability of LD or SD to initiate cellular events which lead to 
cytotoxicity versus their serving as targets in CML we will simply speak of them in terms 
of their serving as targets. It is difficult to evaluate whether SD antigens of H-2K and 
H-2D lead to proliferation. Cells of mouse strains differing by either K  or D stimulate a 
proliferative response, although on the average this response is less than that evoked by 
differences of the strong LD locus. The heat treatment experiment presented in this paper 
suggests that in addition to the H-2K or H-2D locus there are LD-like stimuli in these re- 
gions, the phenotypic expression of which is altered by heat treatment. If such an inter- 
pretation  is  correct,  the  SD  antigens  themselves  are  either  not  stimulatory  at  all  or 
only very weakly so in terms of leading to proliferation. 
Contrary to the  findings  in  the  past,  the  data  analyzed  here  suggests  that  LD 
differences may serve as very weak targets in CML; however they do so to a much 
lesser extent than do SD-type differences. It is not clear that SD antigens are the 
targets  for  cytotoxic  lymphocytes;  SD  antigens  may  serve  as  markers  for loci 
closely linked  to those  determining  the  SD  antigens,  the  products of the  latter 
loci being the targets in  CML. 
It has been argued in the past that the reason that LD differences are not good 
targets in cytotoxicity may be that they are not well expressed on PHA blasts. We 
have  tested  a  series  of  targets  to  determine  whether  LD  antigens  could  be 
detected  in  CML.  Results  with  these  cells  argue  that  it  is  not  simply  PHA 
stimulation which explains the relatively poor target nature of LD. Experiments 
by Alter and  Bach  (15)  using normal lymph node  cells as targets in  CML also 
failed  to  show  strong  cytotoxic activity  against  LD  differences;  although  such 
cells function as excellent targets in combinations differing by both LD and SD. 
These  experiments  taken  together  once  again  support  the  general  dichotomy 
between LD and SD as targets in  CML. 
Two mutant mouse strains have been tested that show unusual patterns in the functional 
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mutation in the H-2  b chromosome of the C57BL/6By mouse (16) which leads to reciprocal 
skin  graft  rejection;  nevertheless,  upon  reciprocal immunization  no  antisera  defining 
SD-type antigens have been evoked. Cells of these strains also stimulate strongly in MLC 
and lead to excellent CML (9).  This could be interpreted as LD differences serving as 
excellent  CML  targets.  Similarly  the  mutant  of  Egorov,  a  spontaneous  mutation 
apparently affecting the H-2D locus product of the H-d  a chromosome, evokes both MLC 
reactivity and skin graft rejection with the parental strain  (17). This might be taken as 
pure SD-type differences causing strong proliferation. One must be cautious in interpret- 
ing these mutations as simple events affecting only LD or SD. It is conceivable that these 
mutations,  while spontaneous,  are not point  mutations but represent something more 
complex which affects multiple closely linked loci. Alternatively LD- and SD-phenotypic 
products may interact at the molecular level. Such an interaction could lead to allosteric 
phenomena  whereby  a  change  in  configuration  of  one  molecule  could  lead  to  a 
configurational change in the second molecule. Further if differences between LD and SD 
are  quantitative,  simple  mutational  events  could  strongly  effect  their  phenotypic 
expression. These mutant strains are thus not of great value in critically dissecting the 
relative roles of LD and SD. 
While  the  functional  distinction  between  H-2  LID  and  SD  components  seems 
strongly supported  by these  many experiments,  it  is not necessary to think of 
them as being qualitatively different at the molecular level. It is conceivable that 
surface density,  distribution,  or rates of shedding  may all affect relative physi- 
ological roles of these components in the reactions we are studying. 
The nature of the LD-SD interaction can be analyzed at two levels--one can 
consider the interaction at the genetic level, or at the cellular level. The addition 
of  an  LD  stimulus,  increases  the  CML  response  to  the  specific  SD  target. 
Whether  the  LD  stimulus  is  essential  to  allow  development  of  CML  is  a 
question which only can be related to a  particular experimental system. Given 
the  heat  treatment  experiment presented  in  this  paper,  we would  argue  that, 
under the present experimental conditions and allowing the interpretation that 
the  heat  treatment  damaged  an  LD-type  stimulus  in  the  K  region,  the 
interaction may well be essential. 
The LD-SD interaction may involve two subpopulations  of lymphocytes or a 
single  responding  population.  Given  two  separate  responding  populations,  we 
might  postulate  that  one  population,  a  proliferating  helper  cell,  responds 
primarily to LD-type stimuli;  this response may then enable a  second popula- 
tion,  the eventual cytotoxic lymphocyte, to react to the  appropriate target (8). 
Whether it is something directly related to proliferation of the first population 
which is essential to allow the second population to respond or whether the LD 
stimulus  evokes  quite  a  separate  response  (which  might  be  distinct  from  the 
proliferative events themselves)  which is  important  in the interaction between 
the two populations is a  subject for further experimentation. 
The  well  characterized  hapten-carrier  system  of  dual  antigenic  control  of 
antibody production may serve as a model for analogy. Here two antigenic signals 
are needed to stimulate separate populations of responding cells and these cells 
then collaborate to produce the final antibody response. 
There appears to be a dichotomy in the hapten-carrier and LD-SD analogy. Hapten-car- 
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can be presented on separate cells. This difference need not be problematic if we consider 
the number of cells responding to different antigenic signals. In the hapten-carrier system 
this number is quite small and therefore contiguous molecules may be important to bring 
two populations into close proximity to allow interaction; the number of cells responding 
to an LD signal is quite high and the probability of an LD-responsive cell contacting its 
collaborative  partner  would  be  much  greater  and  overcome the  need  for  an  antigen 
"bridge." 
The response to LD and SD could also be based on a single responding cell population, 
since the two-cell model is not critically proven. One could either hypothesize that a single 
responding cell has two types of receptors, one recognizing LD differences the other SD 
differences. LD recognition and response might be essential before the cell can recognize 
SD differences and develop into a cytotoxic lymphocyte. Alternatively one might hypothe- 
size, as Cohn has done for antibody production (18) that an associative recognition takes 
place. The LD-different stimulating cell may recognize the eventual cytotoxic effector cell 
and give it a signal which permits it to recognize the SD difference. 
That proliferation has something to do in this overall process is based on a  large 
body  of  indirect  evidence.  In  those  combinations  where  weak  "LD-type" 
differences exist,  ability to develop a  cytotoxic response is consistently linked to 
finding  significant  proliferation.  We  have  also  found  that  the  Mls  locus  of 
Festenstein  (10)  can substitute  for H-2 LD differences in the LD-SD interaction 
(D. J.  Schendel,  unpublished  observations). 
If the import of LD is related to a proliferative stimulus the nature of the signal 
is  more than  nonspecific  expansion  of all  cells.  The strongest  evidence for this 
comes from the  comparison of the  cytotoxic potential  of cultures  stimulated  by 
SD regions alone or those stimulated by both LD and SD. In the latter case not 
only  are  more  cells  recovered  from MLC,  but  also  the  specific  activity of the 
effector  population  has  changed  such  that  only  one-fourth  as  many  cells  are 
required  to  cause  50%  lysis of a  given number of target  cells.  This  can  not  be 
accounted  for if LD  merely serves to stimulate  all  cells  to  divide;  rather there 
must be an enrichment  of the specific effector cells. 
Summary 
H-2 congenic mouse strains were tested in vitro to investigate the genetic control 
of  cell-mediated  lympholysis  (CML).  Combinations  were  selected  such  that 
differences  in  various  segments  of H-2 could  be  examined  for their  ability  to 
stimulate  production of effector cells and to serve as targets for lysis. Particular 
emphasis was directed towards understanding the roles of LD and SD. 
SD-region  differences  are  important  in  the  sensitization  of effector cells and 
they also function  as strong targets for lysis, or as markers for the CML targets. 
LD differences are also important for sensitization of cytotoxic effector cells, but 
they serve only as very weak targets for lysis. 
Collaboration occurs between LD and SD in generation of CML. The nature of 
this interaction can be of two types: together LD and SD can produce CML which 
neither  difference  alone  can  stimulate;  LD  can  enhance  a  CML  response 
stimulated by SD-region differences alone. 1546  GENETIC  CONTROL OF CELL-MEDIATED  LYMPHOLYSIS  IN MOUSE 
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